Another way of putting this: LP should simply create a reason to buy the stock, period. It's hard to understand what her strategy is to withhold information, especially at this point with the trial completed and the ASCO platform a perfect vehicle to deliver more info.
I would like to give Smith the benefit of the doubt, just because his articles are typically well written. But it's painfully obvious that SOS has other agendas, and attempts to spin a narrative to fit hose agendas (whatever it might be or whomever it might serve). I just take him with a grain of salt.